全文获取类型
收费全文 | 18757篇 |
免费 | 1063篇 |
国内免费 | 150篇 |
专业分类
耳鼻咽喉 | 153篇 |
儿科学 | 375篇 |
妇产科学 | 277篇 |
基础医学 | 2342篇 |
口腔科学 | 564篇 |
临床医学 | 1924篇 |
内科学 | 4051篇 |
皮肤病学 | 385篇 |
神经病学 | 2349篇 |
特种医学 | 1276篇 |
外科学 | 2861篇 |
综合类 | 95篇 |
一般理论 | 7篇 |
预防医学 | 616篇 |
眼科学 | 406篇 |
药学 | 979篇 |
中国医学 | 13篇 |
肿瘤学 | 1297篇 |
出版年
2024年 | 14篇 |
2023年 | 155篇 |
2022年 | 319篇 |
2021年 | 539篇 |
2020年 | 349篇 |
2019年 | 413篇 |
2018年 | 500篇 |
2017年 | 440篇 |
2016年 | 569篇 |
2015年 | 636篇 |
2014年 | 792篇 |
2013年 | 913篇 |
2012年 | 1444篇 |
2011年 | 1438篇 |
2010年 | 949篇 |
2009年 | 866篇 |
2008年 | 1295篇 |
2007年 | 1406篇 |
2006年 | 1179篇 |
2005年 | 1197篇 |
2004年 | 1136篇 |
2003年 | 1047篇 |
2002年 | 938篇 |
2001年 | 162篇 |
2000年 | 124篇 |
1999年 | 165篇 |
1998年 | 165篇 |
1997年 | 128篇 |
1996年 | 103篇 |
1995年 | 71篇 |
1994年 | 66篇 |
1993年 | 65篇 |
1992年 | 47篇 |
1991年 | 37篇 |
1990年 | 22篇 |
1989年 | 33篇 |
1988年 | 36篇 |
1987年 | 19篇 |
1986年 | 21篇 |
1985年 | 17篇 |
1984年 | 16篇 |
1983年 | 18篇 |
1982年 | 14篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1979年 | 10篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1974年 | 7篇 |
1972年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
Wenzel Mike Yu Hang Uhlig Annemarie Würnschimmel Christoph Wallbach Manuel Becker Andreas Fisch Margit Chun Felix K. H. Meyer Christian P. Leitsmann Marianne 《International urology and nephrology》2021,53(10):2041-2049
International Urology and Nephrology - To test the value of preoperative and postoperative cystatin C (CysC) as a predictor on kidney function after partial (PN) or radical nephrectomy (RN) in... 相似文献
102.
Matthias Lngin Bruno Reichart Stig Steen Trygve Sjberg Audrius Paskevicius Qiuming Liao Guangqi Qin Maren Mokelke Tanja Mayr Julia Radan Lara Issl Ines Buttgereit Jiawei Ying Ann Kathrin Fresch Alessandro Panelli Stefanie Egerer Andrea Bhr Barbara Kessler Anastasia Milusev Riccardo Sfriso Robert Rieben David Ayares Peter J. Murray Reinhard Ellgass Christoph Walz Nikolai Klymiuk Eckhard Wolf Jan‐Michael Abicht Paolo Brenner 《Xenotransplantation》2021,28(1):e12636
103.
Julia M. Grottenthaler Annette Konzelmann Anette Stiegler Clemens Hinterleitner Sarah M. Bott Thomas Klag Christoph R. Werner Martina Hinterleitner Alfred Königsrainer Anil Batra Nisar P. Malek Silvio Nadalin Christoph P. Berg 《Transplant international》2021,34(11):2257-2265
Alcohol abuse after liver transplantation can seriously impact graft and patient survival. However, to date, there is no defined standard procedure to identify patients consuming alcohol after liver transplantation. The aim of this study was to analyze the diagnostic value and clinical impact of routinely measured urinary ethyl glucuronide (uEtG) – a metabolite of ethanol – in patients after liver transplantation. Data of 362 consecutive patients after liver transplantation who visited the University Hospital of Tuebingen for outpatient follow-up were analyzed. Forty-eight patients (13%) displayed positive uEtG results. The uEtG positive group contained significantly more patients with pretransplant alcoholic liver disease. However, two thirds of the uEtG positive patients had no history of pretransplant alcoholic liver disease. Several clinical parameters were significantly associated with positive uEtG. In order to enable a more cost-effective application of uEtG in the future, a clinical risk score was developed (specificity 0.95). In conclusion, routine testing for uEtG reveals a considerable percentage of patients practicing alcohol intake after liver transplantation. Application of our proposed risk score could help focusing uEtG testing on patients at risk. 相似文献
104.
105.
106.
Laura N. Walti Catrina Mugglin Daniel Sidler Matteo Mombelli Oriol Manuel Hans H. Hirsch Nina Khanna Nicolas Mueller Christoph Berger Katia Boggian Christian Garzoni Dionysios Neofytos Christian van Delden Cédric Hirzel Swiss Transplant Cohort Study 《American journal of transplantation》2021,21(7):2532-2542
Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of solid organ transplantation (SOT). Most PTLD cases are associated with Epstein–Barr virus (EBV) infection. The role of antiviral prophylaxis or rituximab therapy for prevention of PTLD in SOT recipients is controversial. In a nationwide cohort, we assessed the incidence, presentation, and outcome of histologically proven PTLD. We included 4765 patients with a follow-up duration of 23 807 person-years (py). Fifty-seven PTLD cases were identified; 39 (68%) were EBV positive (EBV+ PTLD). Incidence rates for EBV+ PTLD at 1, 2, and 3 years posttransplant were 3.51, 2.24, and 1.75/1000 py and 0.44, 0.25, and 0.29/1000 py for EBV− PTLD. We did not find an effect of antiviral prophylaxis on early and late EBV+ PTLD occurrence (early EBV+ PTLD: SHR 0.535 [95% CI 0.199–1.436], p = .264; late EBV+ PTLD: SHR 2.213, [95% CI 0.751–6.521], p = .150). However, none of the patients (0/191) who received a rituximab-containing induction treatment experienced PTLD, but 57 of 4574 patients without rituximab induction developed PTLD. In an adjusted restricted mean survival time model, PTLD-free survival was significantly longer (0.104 years [95% CI 0.077–0.131]) in patients receiving rituximab as induction treatment. This study provides novel data on the association of rituximab induction and reduced risk for PTLD. 相似文献
107.
Justin Gabriel Schlager Benjamin Kendziora Leilah Patzak Sophie Kupf Christoph Rothenberger Zeno Fiocco Lars E. French Markus Reinholz Daniela Hartmann 《International wound journal》2021,18(4):536
Recent studies showed that the COVID‐19 pandemic caused collateral damage in health care in terms of reduced hospital submissions or postponed treatment of other acute or chronic ill patients. An anonymous survey was sent out by mail to patients with chronic wounds in order to evaluate the impact of the pandemic on wound care. Sixty‐three patients returned the survey. In 14%, diagnostic workup or hospitalisation was cancelled or postponed. Thirty‐six percent could not seek consultation by their primary care physician as usual. The use of public transport or long travel time was not related to limited access to medical service (P = .583). In ambulatory care, there was neither a significant difference in the frequency of changing wound dressings (P = .67), nor in the person, who performed wound care (P = .39). There were no significant changes in wound‐specific quality of life (P = .505). No patient used telemedicine in order to avoid face‐to‐face contact or anticipate to pandemic‐related restrictions. The COVID‐19 pandemic impaired access to clinical management of chronic wounds in Germany. It had no significant impact on ambulatory care or wound‐related quality of life. Telemedicine still plays a negligible role in wound care. 相似文献
108.
109.
110.
Journal of Public Health - Media reporting can influence the perception and development of attitudes through the frequency and the way certain topics are presented. The German Medical Journal... 相似文献